Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
2,094
Views
1
CrossRef citations to date
0
Altmetric
Neurology

Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database

Alex Exuzidesa Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9971-9485
ORCID Icon,
Ning Wua Genentech, Inc., South San Francisco, CA, USA
,
Daniel Sheinsona Genentech, Inc., South San Francisco, CA, USA
,
Carlos Flores Avilea Genentech, Inc., South San Francisco, CA, USA
,
Cristina Costantinob F. Hoffmann-La Roche Ltd., Basel, Switzerland
&
Paris Sidiropoulosb F. Hoffmann-La Roche Ltd., Basel, Switzerland
Pages 581-588 | Received 11 Feb 2021, Accepted 09 Apr 2021, Published online: 05 May 2021

References

  • Kim SM, Kim SJ, Lee HJ, et al. Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord. 2017;10(7):265–289.
  • Huda S, Whittam D, Bhojak M, et al. Neuromyelitis optica spectrum disorders. Clin Med. 2019;19(2):169–176.
  • Hor JY, Asgari N, Nakashima I, et al. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol. 2020;11:501.
  • Wildner, Paula, Stasiołek, Mariusz, Matysiak, Mariola, Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Mult Scler Relat Disord. 2020;37:101452.
  • Cook, Lawrence J, Rose, John W, Alvey, Jessica S, et al. Collaborative international research in clinical and longitudinal experience study in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2019;6(5):e583.
  • Ajmera MR, Boscoe A, Mauskopf J, et al. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica. J Neurol Sci. 2018;384:96–103.
  • Williamson M, McEnany M, Maxion-Bergemann S, et al. Epidemiologic temporal trends of neuromyelitis optic spectrum disorder in the United States From 2000 to 2015. Proceedings of the International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 2018 Aug 22–26; Prague, Czech Republic; 2018.
  • Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92(4):663–679.
  • Beekman J, Keisler A, Pedraza O, et al. Neuromyelitis optica spectrum disorder: patient experience and quality of life. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e580.
  • Stafkey-Mailey D, Boscoe A, Ajmera M, et al. A real-world analysis of relapses and costs of neuromyelitis optica spectrum disorders using a United States administrative claims database. Neurology. 2016;86(16 Supplement):P6.161.
  • Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. 2013;23(6):661–683.
  • Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189.
  • Wingerchuk DM, Weinshenker BG. Neuromyelitis optica spectrum disorder diagnostic criteria: sensitivity and specificity are both important. Mult Scler. 2017;23(2):182–184.
  • Kessler RA, Mealy MA, Levy M. Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic. Curr Treat Options Neurol. 2016;18(1):2.
  • Kulaylat AS, Schaefer EW, Messaris E, et al. Truven health analytics MarketScan databases for clinical research in colon and rectal surgery. Clin Colon Rectal Surg. 2019;32(1):54–60.
  • Hamid SH, Elsone L, Mutch K, et al. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates. Mult Scler. 2017;23(2):228–233.
  • Kadish R, Parker T, Tanvir I, et al. Neuromyelitis Optica Spectrum Disorder (NMOSD): epidemiology, treatments, and outcomes in a single center. Neurology. 2020;94(15 Supplement):4629.
  • Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805–815.
  • Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107–1114.
  • Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485–1489.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.